Epirus Biopharmaceuticals Inc Stock Nasdaq
Equities
US29428P1075
Biotechnology & Medical Research
Financials (USD)
Sales 2014 | 0 | Sales 2015 | 0.7 | Capitalization | 75.33M |
---|---|---|---|---|---|
Net income 2014 | -41M | Net income 2015 | -52M | EV / Sales 2014 | 14,770,294,750 x |
Net cash position 2014 | 14.18M | Net cash position 2015 | 16.68M | EV / Sales 2015 | 83,658,631 x |
P/E ratio 2014 |
-0.83
x | P/E ratio 2015 |
-1.35
x | Employees | - |
Yield 2014 * |
-
| Yield 2015 |
-
| Free-Float | 100% |
1st Jan change | Capi. | |
---|---|---|
-0.02% | 42.11B | |
+43.29% | 40.08B | |
+5.04% | 40B | |
-11.32% | 26.87B | |
+5.25% | 24.58B | |
-23.83% | 18.44B | |
-1.62% | 11.94B | |
+22.75% | 11.66B | |
+6.44% | 11.01B |